Remission rate after transsphenoidal surgery in patients with pathologically confirmed Cushing's disease, the role of cortisol, ACTH assessment and immediate reoperation: A large single center experience

Pituitary

Volumn 16, Issue 4, 2013, Pages 452-458

  Hameed, Nadia ^a   Yedinak, Chris G ^a,b   Brzana, Jessica ^a   Gultekin, Sakir H ^a   Coppa, Nicholas D ^a,b   Dogan, Aclan ^a,b   Delashaw, Johnny B ^c   Fleseriu, Maria ^a,b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

ACTH; Cortisol; Cushing's disease; Remission after surgery; Transsphenoidal surgery

Indexed keywords

CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; HYDROCORTISONE;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CORTICOTROPIN BLOOD LEVEL; CROSS-SECTIONAL STUDY; CUSHING DISEASE; DIABETES INSIPIDUS; FEMALE; FOLLOW UP; HORMONE ACTION; HORMONE DEFICIENCY; HORMONE DETERMINATION; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYDROCORTISONE URINE LEVEL; HYPOPHYSIS ADENOMA; INTRAOPERATIVE PERIOD; MAJOR CLINICAL STUDY; MALE; MICROADENOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; POSTOPERATIVE PERIOD; PREDICTIVE VALUE; PREDICTOR VARIABLE; PRIORITY JOURNAL; RECURRENT DISEASE; REFERENCE VALUE; REMISSION; REOPERATION; RETROSPECTIVE STUDY; TRANSSPHENOIDAL SURGERY; TREATMENT OUTCOME;

ADRENOCORTICOTROPIC HORMONE; ADULT; FEMALE; HUMANS; HYDROCORTISONE; MALE; MIDDLE AGED; PITUITARY ACTH HYPERSECRETION; POSTOPERATIVE PERIOD; REMISSION INDUCTION; REOPERATION; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84888204095     PISSN: 1386341X     EISSN: 15737403     Source Type: Journal    
DOI: 10.1007/s11102-012-0455-z     Document Type: Article

References (34)

1. Locatelli M, Vance ML, Laws ER (2005) Clinical review: the strategy of immediate reoperation for transsphenoidal surgery for Cushing's disease. J Clin Endocrinol Metab 90:5478-5482
2. Ben-Shlomo A, Liu N-A, Melmed S (2011) Pathogenesis of corticotropic tumors. In: Bronstein MD (ed) Cushing's syndrome. Contemporary endocrinology. Humana Press, Totowa, pp 31-40
3. Acebes JJ, Martino J, Masuet C, Montanya E, Soler J (2007) Early post-operative ACTH and cortisol as predictors of remission in Cushing's disease. Acta Neurochir (Wien) 149:471-477
4. Srinivasan L, Laws ER, Dodd RL, Monita MM, Tannenbaum CE, Kirkeby KM, Chu OS, Harsh GR, Katznelson L (2011) The dynamics of post-operative plasma ACTH values following transsphenoidal surgery for Cushing's disease. Pituitary 14:312-317
5. Lindsay JR, Oldfield EH, Stratakis CA, Nieman LK (2011) The postoperative basal cortisol and CRH tests for prediction of long-term remission from Cushing's disease after transsphenoidal surgery. J Clin Endocrinol Metab 96:2057-2064
6. Valassi E, Biller BM, Swearingen B, Giraldi FP, Losa M, Mortini P, Hayden D, Cavagnini F, Klibanski A (2010) Delayed remission after transsphenoidal surgery in patients with Cushing's disease. J Clin Endocrinol Metab 95:601-610
7. Biller BM, Grossman AB, Stewart PM, Melmed S, Bertagna X, Bertherat J, Buchfelder M, Colao A, Hermus AR, Hofland LJ, Klibanski A, Lacroix A, Lindsay JR, Newell-Price J, Nieman LK, Petersenn S, Sonino N, Stalla GK, Swearingen B, Vance ML, Wass JA, Boscaro M (2008) Treatment of adrenocorticotropin-dependent Cushing's syndrome: a consensus statement. J Clin Endocrinol Metab 93:2454-2462
8. Fleseriu M, Loriaux DL, Ludlam WH (2007) Second-line treatment for Cushing's disease when initial pituitary surgery is unsuccessful. Curr Opin Endocrinol Diabetes Obes 14:323-328
9. Fleseriu M, Petersenn S (2012) Medical management of Cushing's disease: what is the future? Pituitary 15:330-341
10. Clayton RN, Raskauskiene D, Reulen RC, Jones PW (2011) Mortality and morbidity in Cushing's disease over 50 years in Stoke-on-Trent, UK: audit and meta-analysis of literature. J Clin Endocrinol Metab 96:632-642
11. Sughrue ME, Shah JK, Devin JK, Kunwar S, Blevins LS Jr (2010) Utility of the immediate postoperative cortisol concentrations in patients with Cushing's disease. Neurosurgery 67:688-695
12. McCance DR, Besser M, Atkinson AB (1996) Assessment of cure after transsphenoidal surgery for Cushing's disease. Clin Endocrinol (Oxf) 44:1-6
13. Blevins LS Jr, Christy JH, Khajavi M, Tindall GT (1998) Outcomes of therapy for Cushing's disease due to adrenocorticotropin-secreting pituitary macroadenomas. J Clin Endocrinol Metab 83:63-67
14. Bochicchio D, Losa M, Buchfelder M (1995) Factors influencing the immediate and late outcome of Cushing's disease treated by transsphenoidal surgery: a retrospective study by the European Cushing's Disease Survey Group. J Clin Endocrinol Metab 80:3114-3120
15. Alwani RA, de Herder WW, de Jong FH, Lamberts SW, van der Lely AJ, Feelders RA (2011) Rapid decrease in adrenal responsiveness to ACTH stimulation after successful pituitary surgery in patients with Cushing's disease. Clin Endocrinol (Oxf) 75:602-607
16. Alwani RA, de Herder WW, van Aken MO, van den Berge JH, Delwel EJ, Dallenga AH, De Jong FH, Lamberts SW, van der Lely AJ, Feelders RA (2010) Biochemical predictors of outcome of pituitary surgery for Cushing's disease. Neuroendocrinology 91:169-178
17. Pouratian N, Prevedello DM, Jagannathan J, Lopes MB, Vance ML, Laws ER Jr (2007) Outcomes and management of patients with Cushing's disease without pathological confirmation of tumor resection after transsphenoidal surgery. J Clin Endocrinol Metab 92:3383-3388
18. Ram Z, Nieman LK, Cutler GB Jr, Chrousos GP, Doppman JL, Oldfield EH (1994) Early repeat surgery for persistent Cushing's disease. J Neurosurg 80:37-45
19. Trainer PJ, Lawrie HS, Verhelst J, Howlett TA, Lowe DG, Grossman AB, Savage MO, Afshar F, Besser GM (1993) Transsphenoidal resection in Cushing's disease: undetectable serum cortisol as the definition of successful treatment. Clin Endocrinol (Oxf) 38:73-78
20. Friedman RB, Oldfield EH, Nieman LK, Chrousos GP, Doppman JL, Cutler GB Jr, Loriaux DL (1989) Repeat transsphenoidal surgery for Cushing's disease. J Neurosurg 71:520-527
21. Patil CG, Veeravagu A, Prevedello DM, Katznelson L, Vance ML, Laws ER Jr (2008) Outcomes after repeat transsphenoidal surgery for recurrent Cushing's disease. Neurosurgery 63:266-270
22. Erickson D, Natt N, Nippoldt T, Young WF Jr, Carpenter PC, Petterson T, Christianson T (2007) Dexamethasone-suppressed corticotropin-releasing hormone stimulation test for diagnosis of mild hypercortisolism. J Clin Endocrinol Metab 92:2972-2976
23. Pereira AM, van Aken MO, van Dulken H, Schutte PJ, Biermasz NR, Smit JW, Roelfsema F, Romijn JA (2003) Long-term predictive value of postsurgical cortisol concentrations for cure and risk of recurrence in Cushing's disease. J Clin Endocrinol Metab 88:5858-5864
24. Utz AL, Swearingen B, Biller BM (2005) Pituitary surgery and postoperative management in Cushing's disease. Endocrinol Metab Clin North Am 34:459-478
25. Hofmann BM, Hlavac M, Kreutzer J, Grabenbauer G, Fahlbusch R (2006) Surgical treatment of recurrent Cushing's disease. Neurosurgery 58:1108-1118; discussion 1108-1118
26. Guilhaume B, Bertagna X, Thomsen M, Bricaire C, Vila-Porcile E, Olivier L, Racadot J, Derome P, Laudat MH, Girard F et al (1988) Transsphenoidal pituitary surgery for the treatment of Cushing's disease: results in 64 patients and long term follow-up studies. J Clin Endocrinol Metab 66:1056-1064
27. Invitti C, Pecori Giraldi F, de Martin M, Cavagnini F (1999) Diagnosis and management of Cushing's syndrome: results of an Italian multicentre study. Study group of the Italian society of endocrinology on the pathophysiology of the hypothalamic-pituitary-adrenal axis. J Clin Endocrinol Metab 84:440-448
28. Estrada J, Garcia-Uria J, Lamas C, Alfaro J, Lucas T, Diez S, Salto L, Barcelo B (2001) The complete normalization of the adrenocortical function as the criterion of cure after transsphenoidal surgery for Cushing's disease. J Clin Endocrinol Metab 86:5695-5699
29. Burke CW, Adams CB, Esiri MM, Morris C, Bevan JS (1990) Transsphenoidal surgery for Cushing's disease: does what is removed determine the endocrine outcome? Clin Endocrinol (Oxf) 33:525-537
30. Rees DA, Hanna FW, Davies JS, Mills RG, Vafidis J, Scanlon MF (2002) Long-term follow-up results of transsphenoidal surgery for Cushing's disease in a single centre using strict criteria for remission. Clin Endocrinol (Oxf) 56:541-551
31. Roelfsema F, Keenan DM, Veldhuis JD (2011) Endogenous ACTH concentration-cortisol secretion dose analysis unmasks decreased ACTH potency in Cushing's disease with restoration after successful pituitary adenomectomy. J Clin Endocrinol Metab 96:3768-3774
32. Veldhuis JD, Iranmanesh A, Lizarralde G, Johnson ML (1989) Amplitude modulation of a burstlike mode of cortisol secretion subserves the circadian glucocorticoid rhythm. Am J Physiol 257:E6-E14
33. Czirjak S, Bezzegh A, Gal A, Racz K (2002) Intra- and postoperative plasma ACTH concentrations in patients with Cushing's disease cured by transsphenoidal pituitary surgery. Acta Neurochir (Wien) 144:971-977
34. Graham KE, Samuels MH, Raff H, Barnwell SL, Cook DM (1997) Intraoperative adrenocorticotropin levels during transsphenoidal surgery for Cushing's disease do not predict cure. J Clin Endocrinol Metab 82:1776-1779